Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03003962
Title Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Durvalumab

Cisplatin + Gemcitabine

Carboplatin + Gemcitabine

Carboplatin + Pemetrexed Disodium

Cisplatin + Pemetrexed Disodium

Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST